The status of Japanese contender Epicharis is in question for the June 10 Belmont Stakes Presented by NYRA Bets (G1) after the colt was treated with bute June 7 and did not go out to train June 8 at Belmont Park.
The Kentucky HBPA said Aug. 31 it is "frustrated and extremely disappointed" with the decision by Kentucky Gov. Steve Beshear to override a vote by a legislative committee that found new equine medical rules deficient.
Two national organizations said Aug. 28 they find it "troubling" factions in Kentucky horse racing are opposing medication regulations proposed by the Kentucky Horse Racing Commission but shot down by a legislative committee.
New York is returning to a standard banning the use of phenylbutazone in horses in the 48 hours leading up to a race. The state Racing and Wagering Board on Feb. 29 adopted a final rule revising the Bute time and threshold.
Trainer Dale Romans is to begin serving a seven-day suspension Feb. 13 stemming from a positive test on one of his horses for phenylbutazone after a race last November at Aqueduct, Daily Racing Form reports.
A Louisiana Senate committee rejected an emergency rule approved by the Louisiana State Racing Commission to lower the testing threshold level for phenylbutazone from 5 micrograms per milliliter to 2 micrograms.
The Model Rules Committee of the Association of Racing Commissioners International has voted 12-0, with one abstention, to recommend lowering the threshold of the non-steroidal anti-inflammatory drug Phenylbutazone.
Laboratories that test samples for the presence of drugs in California, Delaware, Kentucky, New York, Pennsylvania, West Virginia, and other states have signed letters of intent to submit to accreditation.
Kentucky officials will consider regulations for use of shock-wave therapy in racehorses and also whether money for equine drug research should be spent on establishing threshold levels and withdrawal times for permitted medications.
The use of phenylbutazone would be permitted on race days in New York under legislation recently proposed by Assemblyman Gary Pretlow, a Yonkers Raceway booster. In New York, the pain-killer can't be administered to a horse within 48 hours of a race.
Mrs. John Magnier and Michael Tabor's Montjeu will not be administered lasix prior to the Breeders' Cup Turf (gr. IT), but the 4-year-old colt will be racing on bute in the 1 1/2-mile race, trainer John Hammond told Sporting Life.